Douglas B. Lowrie

7.2k total citations · 1 hit paper
121 papers, 5.6k citations indexed

About

Douglas B. Lowrie is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Douglas B. Lowrie has authored 121 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 67 papers in Immunology and 42 papers in Epidemiology. Recurrent topics in Douglas B. Lowrie's work include Tuberculosis Research and Epidemiology (67 papers), Mycobacterium research and diagnosis (35 papers) and Immune responses and vaccinations (20 papers). Douglas B. Lowrie is often cited by papers focused on Tuberculosis Research and Epidemiology (67 papers), Mycobacterium research and diagnosis (35 papers) and Immune responses and vaccinations (20 papers). Douglas B. Lowrie collaborates with scholars based in United Kingdom, China and Tanzania. Douglas B. Lowrie's co-authors include Ricardo E. Tascon, M. Joseph Colston, P. S. Jackett, V R Aber, Célio Lopes Silva, Evangelos Stavropoulos, Amalio Telenti, Stewart T. Cole, K Schopfer and L Matter and has published in prestigious journals such as Nature, The Lancet and Nature Medicine.

In The Last Decade

Douglas B. Lowrie

118 papers receiving 5.2k citations

Hit Papers

Detection of rifampicin-resistance mutations in Mycobacte... 1993 2026 2004 2015 1993 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
    1993 1.0k citations Douglas B. Lowrie, M. Joseph Colston et al. profile →

Peers

Douglas B. Lowrie
Sheldon L. Morris United States
Olivier Neyrolles France
Delphi Chatterjee United States
Sung Jae Shin South Korea
Maria Laura Gennaro United States
Mark J. Hickey United States
Rui Appelberg Portugal
Père-Joan Cardona Spain
Ann Williams United Kingdom
Lee W. Riley United States
Sheldon L. Morris United States
Douglas B. Lowrie
Citations per year, relative to Douglas B. Lowrie Douglas B. Lowrie (= 1×) peers Sheldon L. Morris

Countries citing papers authored by Douglas B. Lowrie

Since Specialization
Citations

This map shows the geographic impact of Douglas B. Lowrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Lowrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Lowrie more than expected).

Fields of papers citing papers by Douglas B. Lowrie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Lowrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Lowrie. The network helps show where Douglas B. Lowrie may publish in the future.

Co-authorship network of co-authors of Douglas B. Lowrie

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Lowrie. A scholar is included among the top collaborators of Douglas B. Lowrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Lowrie. Douglas B. Lowrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Mingquan, Yan Wang, Douglas B. Lowrie, et al.. (2025). Rapid detection of drug resistance in Mycobacterium tuberculosis clinical isolates for first-line antitubercular drugs by using a novel reporter mycobacteriophage. Frontiers in Cellular and Infection Microbiology. 15. 1589236–1589236.
2.
3.
Liu, Xuhui, Yuan Yuan, Douglas B. Lowrie, et al.. (2022). An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China. Frontiers in Immunology. 13. 926781–926781. 13 indexed citations
4.
Wu, Juan, Heng Yang, Zhidong Hu, et al.. (2021). Mycobacterium tuberculosis Rv3628 is an effective adjuvant via activation of dendritic cells for cancer immunotherapy. Molecular Therapy — Oncolytics. 23. 288–302. 7 indexed citations
5.
Hu, Zhidong, Ka‐Wing Wong, Ping Ji, et al.. (2017). Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice. Molecular Therapy. 25(5). 1222–1233. 45 indexed citations
6.
Zhang, Lijun, Douglas B. Lowrie, & Hong‐Hao Zhou. (2011). Proteomic progress in studying tuberculosis from 2010 to 2011. 2(4). 395–400. 1 indexed citations
7.
Rook, G.A.W., Douglas B. Lowrie, & Rogélio Hernández‐Pando. (2007). Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?. The Journal of Infectious Diseases. 196(2). 191–198. 39 indexed citations
8.
Vordermeier, H. M., Douglas B. Lowrie, & R. Glyn Hewinson. (2003). Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting. Veterinary Microbiology. 93(4). 349–359. 41 indexed citations
9.
Tascon, Ricardo E., et al.. (2003). Repeated Use of Qiagen Columns in Large-Scale Preparation of Plasmid DNA. Humana Press eBooks. 29. 35–36. 1 indexed citations
10.
Tollefsen, Stig, Martin Vordermeier, I. Olsen, et al.. (2003). DNA Injection in Combination with Electroporation: a Novel Method for Vaccination of Farmed Ruminants. Scandinavian Journal of Immunology. 57(3). 229–238. 76 indexed citations
11.
Johansen, Pål, Panagiota Stamou, Ricardo E. Tascon, Douglas B. Lowrie, & Brigitta Stockinger. (2003). CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells. European Journal of Immunology. 34(1). 91–97. 28 indexed citations
12.
Chambers, Mark A., D.A. Stagg, Dolores Gavier‐Widén, et al.. (2001). A DNA vaccine encoding MPB 83 from Mycobacterium bovis reduces M bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles). Research in Veterinary Science. 71(2). 119–126. 12 indexed citations
13.
Lowrie, Douglas B. & Robert G. Whalen. (2000). DNA vaccines : Methods and protocols. Annales de biologie clinique. 58(5). 25 indexed citations
14.
Lowrie, Douglas B. & Célio Lopes Silva. (2000). Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine. 18(16). 1712–1716. 22 indexed citations
15.
Ragno, Silvia, M. Joseph Colston, Douglas B. Lowrie, et al.. (1997). Protection of rats from adjuvant arthritis by immunization with naked dna encoding for mycobacterial heat shock protein 65. Arthritis & Rheumatism. 40(2). 277–283. 58 indexed citations
16.
Tascon, Ricardo E., et al.. (1996). Vaccination against tuberculosis by DNA injection. Nature Medicine. 2(8). 888–892. 425 indexed citations
17.
Lowrie, Douglas B., et al.. (1995). Vaccination against Tuberculosis. International Archives of Allergy and Immunology. 108(4). 309–312. 29 indexed citations
18.
Lowrie, Douglas B., Ricardo E. Tascon, M. Joseph Colston, & Célio Lopes Silva. (1994). Towards a DNA vaccine against tuberculosis. Vaccine. 12(16). 1537–1540. 96 indexed citations
19.
20.
Hawkins, B. R., Deborah Higgins, Stephen L. Chan, et al.. (1988). HLA Typing in the Hong Kong Chest Service/British Medical Research Council Study of Factors Associated with the Breakdown to Active Tuberculosis of Inactive Pulmonary Lesions. American Review of Respiratory Disease. 138(6). 1616–1621. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheldon L. Morris Breakdown of academic impact, for papers by Olivier Neyrolles Breakdown of academic impact, for papers by Delphi Chatterjee Breakdown of academic impact, for papers by Sung Jae Shin Breakdown of academic impact, for papers by Maria Laura Gennaro Breakdown of academic impact, for papers by Mark J. Hickey Breakdown of academic impact, for papers by Rui Appelberg Breakdown of academic impact, for papers by Père-Joan Cardona Breakdown of academic impact, for papers by Ann Williams Breakdown of academic impact, for papers by Lee W. Riley
Rankless by CCL
2026